A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
AstraZeneca
Neonc Technologies, Inc.
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc.
Bayer
Taproot Health
Quadriga Biosciences, Inc.
Tocagen Inc.
Novartis
INSYS Therapeutics Inc